Skip to content

Satellite Spinal System Modification

by Medtronic Sofamor Danek, Inc.

510(k) K060415

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESU Traditional NumberK060415 Date5 Jan 2007ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Modification to: Satellite Spinal System
510(k) Number
FDA product code
NVR
FDA applicant
Medtronic Sofamor Danek
Device class
Class III
Advisory committee
Unknown
FDA decision
SESU

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Satellite Spinal System Modification is an Intervertebral Fusion Device With Bone Graft, Solid-Sphere, Lumbar, designed to facilitate spinal stabilization and fusion in the lumbar region. It incorporates solid-sphere components to promote bony integration and structural support between vertebrae, aiding in the treatment of degenerative disc disease or spinal instability.

This device is supplied as a modification to the original Satellite Spinal System and is classified under FDA 510(k) clearance (K060415) as a Class III medical device. It is intended for surgical use in controlled operating room environments and requires sterile handling. The system is reusable per manufacturer specifications, though individual components may vary in sterility and single-use requirements. No MRI safety information is specified, and storage conditions align with standard orthopedic implant protocols.

Other devices from Medtronic Sofamor Danek, Inc.

See all devices from Medtronic Sofamor Danek, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Satellite Spinal System Modification in lumbar spine surgery?

    The Satellite Spinal System Modification is designed to facilitate spinal stabilization and fusion in the lumbar region by using solid-sphere components. These components promote bony integration and structural support between vertebrae, which helps address conditions like degenerative disc disease or spinal instability.

  • Is this device intended for single-use or can it be reused according to manufacturer guidelines?

    The Satellite Spinal System Modification is classified as reusable per the manufacturer’s specifications, though individual components within the system may have varying sterility and single-use requirements. Sterile handling is required, especially in the controlled operating room environment where it is used.

  • How should the Satellite Spinal System Modification be stored to maintain its integrity?

    Storage follows standard orthopedic implant protocols, though specific conditions like temperature or humidity are not detailed in the provided data. Since it is intended for surgical use, it should be kept in a clean, dry environment to prevent contamination until use.

  • Are there any restrictions on using this device with MRI machines?

    The provided data does not specify MRI safety information for the Satellite Spinal System Modification, so its compatibility with MRI machines cannot be confirmed. Caution should be exercised, and pre-procedural checks are recommended if MRI imaging is planned.

  • What regulatory pathway was followed for the approval of this modification?

    The Satellite Spinal System Modification received FDA clearance through a 510(k) submission (K060415) under the traditional review pathway. It is classified as a Class III medical device, indicating it is subject to stringent regulatory oversight due to its surgical use and potential risks.